Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Florida divided over genetically modified mosquitoes
Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses.
Referendum reveals concerns over planned release

Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses, according to the Centre for Infectious Disease Research and Policy.

The Centre say that, in a non-binding referendum, 58 per cent of voters in Monroe County voted in favour of using the mosquitoes. Meanwhile in Key Haven - a neighbourhood where the insects would be released next spring - 65 per cent of voters opposed the idea.

In spite of the need for mosquito control, locals worry that genetically modified mosquitoes may pose an unpredicted environmental threat. It is thought that early reports, which erroneously linked microcephaly to genetically modified mosquitoes, may also have a part to play in the doubt.

The genetically modified mosquitoes are manufactured by British company Oxitec, who plan to assess their effectiveness for fighting Zika.  According to BBC News, Oxitec want to release male insects across a 17-hectare region of Key Haven, a small suburb located on an island on Florida’s southern tip.

The US Food & Drug administration approved Oxitec’s mosquitoes for use in August, saying that, following months of comments from the public, the mosquitos fell under the category of Finding of No Significant Impact (FONSI).

The results of the Florida poll will now be put to board members on 19 November, who will make the final decision on whether the mosquitoes will be used next spring.

Speaking to BBC News, Dr Derric Nimmo, who has been leading Oxitec’s proposed trial in Key Haven, said: We've had six years of releases, involving millions of male mosquitoes, and there have been no reports of any adverse effects."

"It's important we're as transparent as possible... we've been trying to give people the facts and information so they can make an informed choice."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.